Can low-molecular-weight heparin improve the outcome of patients with operable non-small cell lung cancer? An urgent call for research
Chest
.
2004 Aug;126(2):601-7.
doi: 10.1378/chest.126.2.601.
Authors
Marco Alifano
1
,
Giovanni Benedetti
,
Rocco Trisolini
Affiliation
1
Unit of Thoracic Surgery, Maggiore-Bellaria Hospital, Bologna, Italy. marcoalifano@yahoo.com
PMID:
15302749
DOI:
10.1378/chest.126.2.601
No abstract available
Publication types
Review
MeSH terms
Carcinoma, Non-Small-Cell Lung / drug therapy*
Heparin, Low-Molecular-Weight / therapeutic use*
Humans
Lung Neoplasms / drug therapy*
Neoadjuvant Therapy
Substances
Heparin, Low-Molecular-Weight